Overview:
Paper diagnostics are devices made of paper and cellulosic materials to recognize and quantify biomolecules and chemicals affecting health. There has been a rapid increase in interest for paper-based diagnostic methods in recent years. This is because paper is cheap, widely available, easily engineered, biodegradable, combustible, biocompatible, sterilizable, hydrophilic, and easy to functionalize and process into diagnostic devices. Paper diagnostic work on principle of chemical reaction between the coating on the paper and substance that is to be tested, which produces a visible result that can be used for diagnosis. Due to the clear guidelines regarding the meaning of each visible result, paper diagnostics can even be used by untrained patients. This has resulted in a sturdy demand for paper diagnostics from patients suffering from conditions that require regular self-diagnosis.
Increasing prevalence of infectious diseases and lifestyle related diseases have resulted in the growth of point of care diagnostics. In addition rise in the geriatric population globally have also led to the growth opportunities for the paper diagnostics market. Rising acceptance of cost effective and easily available rapid POC diagnostics especially in the developing economies of Asia Pacific region is expected to boost market growth of paper diagnostics over the forecast period. Introduction of paper based sensor, 3D wax printing devices which are technologically advanced, have exhibit potential advantages over the conventional diagnostic technologies, such as user friendliness, disposable nature, and low cost of production are the factors attributing towards the growth of this market.
The Global Paper Diagnostic Market is segmented on the following bases:
Key Players Identified for Paper Diagnostic Market Include:
Alere, Inc., Bio-Rad Laboratories, BiognostiX, Navigene Genetic Science Pvt. Ltd., Micro Essential Laboratory, Kenosha C.V. Siemens Healthcare, GVS Filter Technology, Inc. and Others
This report offers:
